Epithelial NSD2 maintains FMO‐mediated taurine biosynthesis to prevent intestinal barrier disruption

Yue Xu, Xiuying Xiao, Chunxiao Ma, Ziyi Wang, Wenxin Feng, Hanyu Rao, Wei Zhang, Ningyuan Liu, Rebiguli Aji, Xiangjun Meng, Wei‐Qiang Gao, Li LiClinical 2024 · DOI

TL;DR

This study reveals a crucial role for the histone methyltransferase NSD2 in maintaining intestinal barrier integrity by regulating taurine biosynthesis. Loss of NSD2 in intestinal cells leads to barrier disruption and inflammation, which can be ameliorated by taurine supplementation, suggesting a novel therapeutic avenue for inflammatory bowel disease (IBD).

What Problem Does This Paper Address?

Inflammatory bowel disease (IBD), encompassing conditions like Crohn's disease and ulcerative colitis, is a chronic inflammatory disorder characterized by persistent immune activation, mucosal inflammation, and tissue damage. A key factor in IBD pathogenesis is the breakdown of the intestinal epithelial barrier, which normally prevents the inappropriate passage of gut contents and microbes into the underlying tissues. While epigenetic modifications are known to play a role in gastrointestinal health and disease, the specific contribution of the histone methyltransferase NSD2 to IBD has remained largely unexplored. This paper aims to elucidate the role of NSD2 in preventing intestinal barrier disruption and its implications for IBD.

Methods

The researchers employed a multi-faceted approach to investigate NSD2's role in IBD. They analyzed gene expression data from human IBD patients and mouse models to assess NSD2 levels. To study the functional impact of NSD2 deficiency, they generated genetically modified mice with conditional knockout of NSD2 in intestinal epithelial cells (IECs) and also created mice overexpressing NSD2 in IECs.

Key experimental techniques included:

  • Histopathology and Immunohistochemistry (IHC): To assess tissue damage, inflammation, and the expression of specific proteins (like NSD2 and H3K36me2) in colon tissues.
  • Western Blotting: To quantify protein levels of NSD2, H3K36me2, and markers of apoptosis and epithelial integrity.
  • RNA Sequencing (RNA-seq) and RT-qPCR: To identify differentially expressed genes and validate changes in specific gene mRNA levels, particularly those related to inflammation and taurine metabolism.
  • Chromatin Immunoprecipitation Sequencing (ChIP-seq) and ChIP-qPCR: To investigate the direct binding of NSD2 to the promoters of target genes and its effect on histone modifications (H3K36me2).
  • Organoid Culture: To study the behavior of intestinal epithelial cells in a more controlled, in vitro environment, assessing barrier function and cell apoptosis.
  • In vivo IBD Models: Using dextran sodium sulfate (DSS) to induce acute colitis in mice to mimic IBD conditions.
  • Taurine Supplementation: Administering taurine to IBD models to assess its therapeutic potential.

Datasets

The study utilized publicly available gene expression datasets for IBD patients, specifically GSE137344 and GSE57945, to assess NSD2 mRNA levels in healthy controls, ulcerative colitis (UC), and Crohn's disease (CD) specimens.

Key Insights and Ideas

  • NSD2 is Downregulated in IBD: Both human IBD patient samples and DSS-induced IBD mouse models showed significantly reduced levels of NSD2, suggesting a potential protective role for this protein.
  • NSD2 Deficiency Worsens IBD: Mice with NSD2 specifically knocked out in their intestinal epithelial cells exhibited exacerbated symptoms of DSS-induced colitis, including increased weight loss, colon shortening, and more severe histological damage.
  • NSD2 Regulates Epithelial Barrier Function: Loss of NSD2 led to disrupted tight junctions (ZO-1, E-cadherin) and increased intestinal permeability, indicating a compromised epithelial barrier.
  • NSD2 Influences Cell Survival: NSD2 deficiency promoted apoptosis (TUNEL, cleaved caspase-3) and impaired epithelial cell self-renewal (Ki67), contributing to tissue damage.
  • NSD2 is Crucial for Taurine Biosynthesis: The study uncovered a novel mechanism where NSD2, through its histone methyltransferase activity (H3K36me2), directly regulates the expression of flavin-containing monooxygenases (FMOs), enzymes essential for taurine synthesis. Loss of NSD2 led to decreased FMO mRNA and consequently reduced taurine levels.
  • Taurine Supplementation is Protective: Supplementing IBD mice with taurine significantly ameliorated disease severity, restored epithelial barrier integrity, reduced apoptosis, and promoted self-renewal, highlighting taurine's critical role in mitigating NSD2-deficiency-induced IBD.

Key Results

  • NSD2 mRNA levels were significantly lower in IBD patients (UC and CD) compared to healthy controls.
  • In DSS-treated mice, NSD2 deficiency led to a significant increase in inflammatory cell infiltration (CD4+ T cells, macrophages, neutrophils) and elevated pro-inflammatory cytokine production.
  • Epithelial barrier integrity was compromised in Nsd2Vil-KO mice, evidenced by disrupted ZO-1 and E-cadherin staining and increased serum FITC-dextran levels.
  • Apoptosis markers (TUNEL, cleaved caspase-3) were significantly increased, while proliferation marker (Ki67) was decreased in Nsd2Vil-KO mice.
  • ChIP-seq data revealed that NSD2 directly targets the promoters of FMO2, FMO4, and FMO5, leading to H3K36me2 modification and increased FMO expression.
  • Taurine supplementation in Nsd2Vil-KO mice significantly improved body weight, colon length, spleen weight, histology scores, and restored ZO-1 and E-cadherin levels.

Limitations and Future Work

The authors acknowledge that while they've identified a crucial role for NSD2 in regulating FMOs and taurine metabolism, the precise mechanisms by which NSD2 might influence DNA methylation patterns in intergenic regions, and its subsequent effects on Fmo gene expression, require further investigation. They suggest that whole-genome bisulphite sequencing would be a valuable next step to explore these aspects. Additionally, while the study highlights the therapeutic potential of taurine, further research into optimizing taurine delivery and dosage for IBD treatment would be beneficial. The findings also open avenues for exploring NSD2's role in other human disorders associated with its deficiency.

Summary updated

Abstract

In this study, we investigated the role of the histone methyltransferase NSD2 in preventing intestinal barrier disruption by sustaining taurine biosynthesis. NSD2 levels were reduced in both human specimens and mouse models of IBD. We demonstrate that NSD2 loss hinders the process of taurine synthesis in intestinal cells, leading to increased intestinal inflammation. Supplementation with taurine significantly relieved the symptoms caused by NSD2 deficiency. These data suggest that maintenance of NSD2-mediated taurine biosynthesis is vital for preserving the intestinal barrier and attenuating inflammation.
BibTeX
@inproceedings{xu2024epithelial,
  author = {Yue Xu and Xiuying Xiao and Chunxiao Ma and Ziyi Wang and Wenxin Feng and Hanyu Rao and Wei Zhang and Ningyuan Liu and Rebiguli Aji and Xiangjun Meng and Wei‐Qiang Gao and Li Li},
  title = {{Epithelial NSD2 maintains FMO‐mediated taurine biosynthesis to prevent intestinal barrier disruption}},
  booktitle = {Clinical},
  year = {2024},
  doi = {10.1002/ctm2.70128},
}
Figure